Titus B. Ball Sells $36.9K of BeOne Medicines Ltd (ONC) — SEC Form 4, Jun 10, 2026

Open-Market Net Sale · SEC Form 4

−$36,901

Equity position changed by -0.2%

Reporting Owner

Titus B. Ball

CAO

TXN 2026-06-08 · FILED 2026-06-10

Equity Position 70.6K sh 70,765 → 70,629

Equity Change -0.2% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

BeOne Medicines Ltd

ONC CIK 0001651308

Reporting Owner

Name	Relationship
Titus B. Ball CIK 0001675628	CAO

Titus B. Ball at BeOne Medicines Ltd Full insider history

Bought (12 mo) —

Sold (12 mo) $127,342

More from this insider at BeOne Medicines Ltd

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
American Depositary SharesF1 F2 F3	2026-06-08	S - Sale	100 D	$271.06	-$27,106	36	Direct
American Depositary SharesF1 F2 F4	2026-06-08	S - Sale	36 D	$272.08	-$9,795	0	Direct

Non-Derivative Holdings

Title	Shares Held	Ownership
Ordinary Shares	70,629	Direct

Footnotes (4)

F1: Each American Depositary Share represents 13 Ordinary Shares. Show more
F2: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Show more
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.00 to $271.48, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Show more
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.00 to $272.24, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 2 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at BeOne Medicines Ltd

GET /v1/forms/4/0001675628-26-000001 API docs